Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death

Background. Evidence is sparse regarding the optimal construction of regimens to treat multidrug-resistant (MDR) tuberculosis disease due to strains of Mycobacterium tuberculosis resistant to at least both isoniazid and rifampin. Given the low potency of many second-line antituberculous drugs, we hy...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Infect Dis
Hoofdauteurs: Velásquez, Gustavo E., Becerra, Mercedes C., Gelmanova, Irina Y., Pasechnikov, Alexander D., Yedilbayev, Askar, Shin, Sonya S., Andreev, Yevgeny G., Yanova, Galina, Atwood, Sidney S., Mitnick, Carole D., Franke, Molly F., Rich, Michael L., Keshavjee, Salmaan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2014
Onderwerpen:
Articles and Commentaries
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305127/
https://ncbi.nlm.nih.gov/pubmed/24729493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu209
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items